explore -WSS

explore

author：hotspot 2025-10-01 22:58:49 - browse：47442

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Key House Republican on health care plans exit from Congress

WSS

Robert F. Kennedy is pitching centrism on health, even on abortion

FTC loses bid to block Novant's North Carolina hospital merger

Medicare threatens to cut off funding for HCA's Mission hospital

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

What we’ve learned from the Aduhelm mess

How digital tools helped lower hypertension in marginalized patients

leisure time

explore

hotspot

Cancer drug shortages should be causing more outrage

Senators start work on Medicare physician payment reform

Novavax promises a turnaround & Lilly roils the obesity market

Medicare Advantage proposed rates disappoint insurers

Psychedelics group wrestles with new pharma identity

PhRMA lawsuit over Medicare drug price negotiation tossed

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast: How biotech is using artificial intelligence

In Memoriam: Notable people who died in 2023

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

knowledge

Vaccine advisory panel ACIP left half staffed by HHS

For pregnant people, addiction treatment shouldn't mean a call to child protective services

ASCO Takeaways: Winners, snoozers, and the art of cancer care

PhRMA lawsuit over Medicare drug price negotiation tossed

Stopping antidepressants leads to symptoms for 1 in 6 patients

Data don't support strong claims for Covid

hotspot

Wikipedia

Wikipedia

entertainment